Your browser is no longer supported. Please, upgrade your browser.
SNY Sanofi daily Stock Chart
Index- P/E21.68 EPS (ttm)1.90 Insider Own16.40% Shs Outstand2.75B Perf Week-6.56%
Market Cap113.06B Forward P/E13.17 EPS next Y3.13 Insider Trans0.00% Shs Float2.37B Perf Month-1.65%
Income5.01B PEG2.97 EPS next Q0.77 Inst Own9.80% Short Float0.16% Perf Quarter0.81%
Sales39.57B P/S2.86 EPS this Y4.10% Inst Trans0.92% Short Ratio1.73 Perf Half Y-18.26%
Book/sh25.22 P/B1.63 EPS next Y-0.16% ROA- Target Price52.00 Perf Year-17.35%
Cash/sh3.83 P/C10.76 EPS next 5Y7.30% ROE- 52W Range37.63 - 54.98 Perf YTD-3.52%
Dividend1.63 P/FCF- EPS past 5Y-4.40% ROI6.50% 52W High-26.69% Beta0.98
Dividend %3.96% Quick Ratio1.10 Sales past 5Y0.50% Gross Margin68.70% 52W Low7.11% ATR0.80
Employees115631 Current Ratio1.50 Sales Q/Q8.90% Oper. Margin35.40% RSI (14)35.80 Volatility1.56% 1.33%
OptionableYes Debt/Eq0.29 EPS Q/Q4.10% Profit Margin26.60% Rel Volume0.40 Prev Close41.15
ShortableYes LT Debt/Eq0.23 EarningsApr 29 BMO Payout41.40% Avg Volume2.13M Price40.31
Recom2.30 SMA20-6.49% SMA50-2.49% SMA200-10.73% Volume487,908 Change-2.05%
May-03-16Downgrade HSBC Securities Buy → Hold
Dec-10-15Downgrade Exane BNP Paribas Neutral → Underperform
Dec-01-15Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-09-15Downgrade Bernstein Outperform → Mkt Perform
Oct-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-22-15Upgrade Citigroup Sell → Neutral
Apr-15-15Initiated Societe Generale Buy
Aug-03-12Downgrade Standpoint Research Buy → Hold
Jan-11-11Downgrade Jefferies Buy → Hold
Nov-16-09Initiated Deutsche Securities Buy
Oct-14-09Upgrade UBS Sell → Neutral
Aug-28-09Upgrade JP Morgan Neutral → Overweight
Jun-29-09Downgrade JP Morgan Overweight → Neutral
May-28-09Upgrade Citigroup Hold → Buy
Apr-30-09Upgrade JP Morgan Neutral → Overweight
Mar-23-09Upgrade Jefferies & Co Underperform → Hold
Mar-17-09Initiated Credit Suisse Outperform
Feb-19-09Upgrade JP Morgan Underweight → Neutral
Jan-26-09Initiated Jefferies & Co Underperform
Nov-07-08Downgrade UBS Neutral → Sell
May-04-16 10:43AM  Pfizer eyes this San Francisco biotech involved in tight acquisition war at American City Business Journals
10:39AM  Sanofi says sees 'strong strategic' fit with Medivation Reuters
10:16AM  Sanofi says sees "strong strategic" fit with U.S. cancer firm Medivation Reuters
10:11AM  Who Will Win Medivation: Pfizer or Sanofi? Yahoo Finance Contributors
09:07AM  A Look at Vertexs Cystic Fibrosis Patient Opportunity Market Realist
May-03-16 06:33PM  Forget Allergan: Pfizer Has Its Sights On This Cancer Drugmaker at Investor's Business Daily
06:28PM  Relypsa Taps Debt Market: Yeah, Thats Bullish Yahoo Finance Contributors
06:04PM  Exclusive: Pfizer approaches Medivation about potential takeover - sources Reuters
05:41PM  What Sent Medivation, Inc.'s Shares Soaring 25.1% In April at Motley Fool
05:38PM  Baby Powder Cancer Suits Cloud Johnson and Johnson Zacks
05:12PM  Regeneron Pharmaceuticals Inc Has a Lot to Prove on May 5 at Motley Fool
02:30PM  Hulu Takes Aim at DISH and Sony in Live Streaming at Investopedia
11:53AM  Medivation: Sanofi's Bid 'Significantly Undervaluing' Pipeline at
10:41AM  FEZ: An ETF Performance Case Study at Investopedia
10:34AM  Sanofi :SNY-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
07:05AM  Sanofi downgraded by HSBC Securities
May-02-16 11:28AM  Medivation: Why a Takeover Just Got a Little Tougher at
May-01-16 01:09PM  The Next Stock Warren Buffett May Sell at Motley Fool
Apr-29-16 09:20PM  DODFX: Dodge & Cox International Stock Fund Performance Case Study at Investopedia
07:08PM  [$$] Sanofi Seeks Talks With Medivation Over $9.3 Billion Offer at The Wall Street Journal
05:22PM  Worst may be over for embattled pharma Yahoo Finance Contributors
02:38PM  Here's What Medivation Said In Its Rejection Letter To Sanofi Benzinga
01:10PM  Why These Five Stocks Are on the Move Today? at Insider Monkey
12:30PM  AstraZeneca, Pfizer Said Among Firms Weighing Medivation Bid at Bloomberg
11:50AM  Medivation's Right to Play Hard-To-Get at Bloomberg
10:56AM  [$$] Medivation Rejects Sanofi's Takeover Bid at The Wall Street Journal
10:50AM  Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation at TheStreet
10:17AM  Medivation Rejects Sanofis Buyout Bid; Sanofi Remains Committed at Investor's Business Daily
10:11AM  Sanofi, Medivation dig in for big biotech takeover battle Reuters
09:56AM  Medivation Or Otherwise, AstraZeneca Could Still Have Deals in the Tank at The Wall Street Journal
09:49AM  Medivation rejects Sanofi bid, Sanofi to go to shareholders AP
09:39AM  Medivation just rejected Sanofi's $9.3 billion takeover bid Business Insider
09:19AM  Medivation board rejects Sanofi's $9.3 billion takeover offer Reuters
09:16AM  Sanofi says committed to Medivation takeover Reuters
09:05AM  Medivation board rejects Sanofi's $9.3 bln takeover offer Reuters
09:00AM  Medivation Rejects Sanofi's Unsolicited $9.3 Billion Offer at Bloomberg
07:37AM  Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates PR Newswire
05:07AM  Sanofi Q1 2016 Results PR Newswire
04:52AM  Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation Reuters
02:13AM  Sanofi profits stable, strong sales in emerging markets AP
01:40AM  Sanofi confident can win Medivation shareholder support for bid Reuters
01:30AM  Sanofi Profit Little Changed as Drugmaker Pursues Medivation at Bloomberg
12:38AM  [$$] Drugmakers Place Big Bets on Cancer Medicines at The Wall Street Journal
Apr-28-16 05:34PM  [$$] Drugmakers Place Big Bets on Cancer Medicines at The Wall Street Journal
04:23PM  Medical M&A Rules The Day As Abbott, AbbVie Make Buys, Sanofi Bids at Investor's Business Daily
04:05PM  Big Pharma grooves $20 billion M&A dance with 2 Bay Area biotechs at American City Business Journals
03:01PM  Takeover Thursday CNBC
02:36PM  Dealpolitik: Different Defense Playbooks for Tribune, Medivation at The Wall Street Journal
02:29PM  Sanofi's Bid for Medivation Is Too Low at Motley Fool
01:41PM  [$$] Three pharma deals worth $45bn reignite M&A boom at Financial Times
01:30PM  $40 Billion Takeover Has Big Pharma Giddy at TheStreet
01:05PM  Sanofi launches $9.3 blillion fight for U.S. cancer firm Medivation Reuters
01:03PM  Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation Reuters
11:50AM  Why Investors Are Buzzing About These Stocks Today at Insider Monkey
11:49AM  Sanofi makes $9.3 billion bid for American firm Medivation AP
10:55AM  Sanofi Goes Public With $9.3 Billion Bid For Cancer Drugmaker Medivation at Investor's Business Daily
10:27AM  Medivation (MDVN) Stock Surges on Sanofi Bid at TheStreet
10:21AM  [$$] Sanofi / Medivation: Deal-Making Déjà Vu Comes With Added Competition at The Wall Street Journal
10:17AM  Medivation shares rise above Sanofi takeover bid at CNBC
10:11AM  Sanofi Wants To Acquire Medivation For $52.50 Per Share Benzinga
09:41AM  [$$] Sanofi makes $9.3bn unsolicited cash offer for Medivation at Financial Times
08:45AM  Why Earnings Season Could Be Great for Sanofi (SNY) Zacks
08:25AM  Sanofi makes $9.3-billion bid for San Francisco drug company Medivation at Los Angeles Times
07:00AM  Sanofi Presses Medivation to Hold Talks After $9.3B Offer at TheStreet
06:25AM  [$$] Sanofi Makes $9.3 Billion Bid for U.S. Cancer Drugmaker at The Wall Street Journal
05:49AM  April 28 Premarket Briefing: 10 Things You Should Know at TheStreet
04:38AM  Sanofi Offers to Acquire Medivation for $52.50/Share in Cash Benzinga
02:17AM  France's Sanofi makes $9.3 bln bid for U.S. biotech Medivation Reuters
02:07AM  Sanofi Stalks Medivation With $9.3 Billion on Being Spurned at Bloomberg
Apr-27-16 12:18PM  Sanofi US Collaborates with Duke University and Massachusetts General Hospital on Big Data and Type 2 Diabetes PR Newswire
07:35AM  MannKind and Its CEO Fail Simple Financial Literacy Test at TheStreet
Apr-26-16 02:53PM  Stocks Are Mixed as Oil Jumps 3% at TheStreet
01:05PM  ImmunoGen hires former Shire, Genzyme exec as new CEO at American City Business Journals
10:00AM  FEZ vs. IEV: Comparing Europe ETFs at Investopedia
Apr-24-16 07:13PM  [$$] Vaccines are among big pharma's best-selling products at Financial Times
Apr-22-16 06:00PM  Biogen Inc Earnings Explode Higher, Revenue Not So Much at Motley Fool
Apr-21-16 06:57PM  Epizyme (EPZM) Q1 Earnings: Can the Stock Surprise? Zacks
03:59PM  Why Relypsa Spiked Today and a Letter to the CEO Yahoo Finance Contributors
Apr-19-16 01:00AM  [$$] Sanofi to Expand Belgium Plant at The Wall Street Journal
Apr-18-16 12:15PM  Medivation Rises On Cancer Drug Data, AstraZeneca Buyout Rumor
11:47AM  Will Weak Alcon Sales Hurt Novartis' (NVS) Q1 Earnings?
11:33AM  SAP (SAP) to Report Q1 Earnings: Can the Stock Surprise?
10:34AM  Medivation (MDVN) Stock Surges on Takeover Speculation at TheStreet
09:39AM  Medivation: It's Not Just M&A at
09:00AM  New Data Suggesting Positive Effects of Sanofi Genzymes Lemtrada® (alemtuzumab) on Brain Volume Loss and Retinal Nerve Fibers to be Presented at AAN Business Wire
Apr-17-16 03:27PM  Relypsa's Wild Rumors and the Facts that Were Ignored
Apr-15-16 12:12PM  [$$] Sanofi wins WHO support for dengue fever vaccine at Financial Times
10:30AM  OFFICIAL-UPDATE 1-WHO group backs Sanofi's vaccine in areas with high dengue rates
09:14AM  [$$] WHO Recommends Sanofi's Dengue Vaccine at The Wall Street Journal
09:03AM  IoT Analytics And Dell Statistica Deliver Time Compression at Forbes
07:22AM  Strategic Advisory Group of Experts on Immunization Convened by the World Health Organization Recommends Use of Sanofi Pasteur's Dengue Vaccine in Endemic Countries PR Newswire
06:22AM  WHO group backs Sanofi's vaccine in areas with high dengue rates
Apr-14-16 10:03AM  Better Buy: MannKind Corporation vs. Sanofi at Motley Fool
08:00AM  American CryoStem Appoints Nobel Prize Nominee and One of the Leading Stem Cell Experts Vincent C. Giampapa, M.D. to Its Medical and Scientific Advisory Board Marketwired
Apr-13-16 01:20PM  This is Why Everyone Wants to Buy Medivation at
11:37AM  Here's Why Medivation (MDVN) Stock is Spiking Today at TheStreet
11:06AM  What Are Shires Major Valuation Drivers in Fiscal 2016?
Apr-12-16 07:15PM  Valeant Dives As Bondholder Seeks Default; Buyout Buzz Lifts Medivation
06:41PM  Medivation: Biotech's Most Wanted? at
06:37PM  You Cant Smooth The Bumps
Sanofi researches, develops, manufactures, and markets various therapeutic solutions. The company operates in three segments: Pharmaceuticals, Vaccines, and Animal Health. It offers Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; Toujeo, an insulin glargine; and Afrezza, an inhaled insulin. The company also provides Praluent, a human monoclonal antibody; and Multaq, a multichannel blocker with anti-arrhythmic properties. In addition, it offers Cerezyme, an enzyme replacement therapy to treat gaucher disease; cerdelga, an oral therapy for Gaucher disease Type 1; Myozyme/Lumizyme for the pompe disease treatment; Fabrazyme for fabry disease treatment; and Aldurazyme to treat mucopolysaccharidosis Type 1, as well as provides Aubagio and Lemtrada for multiple sclerosis. In addition, it provides Jevtana for prostate cancer; Taxotere for breast, prostate, gastric, lungs, and head and neck cancer treatment; Eloxatin for the treatment of stage III colon cancer; Thymoglobulin to treat acute rejection; Mozobil for treating hematologic malignancies; and Zaltrap for oxaliplatin resistant metastatic colorectal cancer. Further, the company offers other prescription drugs, such as Plavix/Iscover for atherothrombosis and acute coronary syndrome; Lovenox/Clexane for the treatment of venous thromboembolism; Aprovel/Avapro/Karvea for hypertension and nephropathy; Renagel/Renvela to treat chronic kidney disease; Allegra/Telfast to treat seasonal allergic rhinitis and uncomplicated hives; Stilnox/Ambien/Myslee for insomnia treatment; and Synvisc/Synvisc-One for the treatment of osteoarthritis pain. Additionally, it offers consumer health care products and generic medicines; and vaccine and animal health products. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerFeb 17Buy393.7180,00031,496,72823,353,665Feb 18 05:45 PM
Sanofi10% OwnerFeb 16Buy391.2381,15731,751,18223,273,665Feb 18 05:45 PM
Sanofi10% OwnerJan 12Buy465.0483,93839,034,66023,192,508Jan 14 05:46 PM
Sanofi10% OwnerNov 03Buy10.00900,0009,000,0003,218,899Nov 05 02:37 PM
Sanofi10% OwnerOct 06Buy472.3311,0405,214,51923,108,570Oct 08 05:50 PM
Sanofi10% OwnerOct 06Buy459.7180,53837,024,19723,097,530Oct 08 05:45 PM
Sanofi10% OwnerJul 27Buy537.4810,6395,718,27222,869,783Jul 29 05:46 PM